Corticosteroid treatment of kidney disease in a patient with familial lecithin-cholesterol acyltransferase deficiency
✍ Scribed by Przemysław Miarka; Barbara Idzior-Waluś; Marek Kuźniewski; Małgorzata Waluś-Miarka; Tomasz Klupa; Władysław Sułowicz
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 433 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1342-1751
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Erythrocytes from patients with familial lecithin:cholesterol acyltransferase (LCAT) deficiency have been shown to exhibit an increase in membrane fluidity which is surprisingly small in view of the extensive alterations both in membrane lipicl composition (namely, an elevation in chole
In this study, plasma HDL fractions were separated by ultracentrifugation and apo A-I containing lipoproteins (A-I Lp) were then isolated using anti-apo A-I immunoaffinity chromatography. The A-I Lp were further separated into two fractions with the use of anti-apo A-II immunoaffinity chromatography